Last reviewed · How we verify
NCT04397666: P20/09
RT-PCR on Conjunctival Sample for the Detection of SARS-CoV-2 in Patients With Covid-19
NA trial testing conjunctival RT PCR in SARS-CoV Infection in 68 participants. Status unknown.
15 December 2020
Quick facts
| Lead sponsor | Versailles Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | other |
| Enrollment | 68 |
| Start date | 15 May 2020 |
| Primary completion | 15 December 2020 |
| Estimated completion | 15 December 2021 |
| Sites | 1 location across France |
Drugs / interventions tested
- conjunctival RT PCR
Conditions studied
- SARS-CoV Infection — all drugs for SARS-CoV Infection →
- Pinkeye — all drugs for Pinkeye →
Sponsor
Versailles Hospital
Who can join
18 and older, any sex, with SARS-CoV Infection or Pinkeye. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
the purpose of the study is to study the detection of SARS-Cov-2 virus in the conjunctiva of covid-19 patients and the presence or absence of conjunctivitis in these patients
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04397666
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV Infection
Currently open trials in the same condition.
- NCT05886816 — Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19 · Phase 2 · recruiting
- NCT04802408 — SARS-Cov-2 (COVID-19) Nasal Pharyngeal and Oral Pharyngeal Wash (SNOW) Trial · Phase 2, PHASE3 · active not recruiting
- NCT04815096 — Imaging Immune Activation in COVID-19 · Phase 2 · recruiting
- NCT04747522 — Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19) · active not recruiting
- NCT04579471 — Prevalence and Outcome of SARS-CoV-2 Infection & COVID-19 in Transplant Recipients: The COVITRA Study · recruiting
Other Versailles Hospital trials
Trials by the same sponsor.
- NCT07369245 — Techniques for Activating Consciousness (TAC) for Outpatients With Moderate to Severe Alcohol Addiction · NA · not yet recruiting
- NCT07383779 — Targeted Hypothermia Versus Targeted Normothermia After Convulsive Refractory Status Epilepticus · Phase 3 · not yet recruiting
- NCT06835491 — Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac · Phase 3 · recruiting
- NCT07476755 — Cross-cultural Adaptation and Validation of the French Version of the Social Media Disorder Scale for Parents in a Sampl · completed
- NCT06650813 — Adapting the FACETS Program to Sickle Cell Disease · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04397666 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Versailles Hospital
- Last refreshed: 9 August 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04397666.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing